Review
Sep 2026
Targeting the Epigenetic–Immune Axis in Acute Myeloid Leukemia: Current Advances and Future Directions
Ep epigenetic dysregulation is highlighted as both a fundamental driver of leukemogenesis and a clinically actionable therapeutic interface that may enable more rational treatment sequencing and personalized AML management.
Devangi Ghosh, Mohd Ayoub, Surajit Karmakar et al.
· Current Oncology Reports · 0 citations